Drug
Vericiguat
Vericiguat: highest development phase Phase 2/3, developed by Merck. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2/3
- Developer
- Merck
Trials
| Drug | Phase | Indication |
|---|---|---|
| Vericiguat tablet NCT05714085 | Phase 2/3 | Heart Failure |
Latest
No recent events.
Follow Vericiguat on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.